Skip to Content

Champions Oncology Inc CSBR

Morningstar Rating
$4.66 −0.24 (4.90%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

CSBR is trading at a 745% premium.
Price
$4.88
Fair Value
$5.76
Uncertainty
Very High
1-Star Price
$95.37
5-Star Price
$6.18
Economic Moat
Xflxv
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CSBR is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$4.90
Day Range
$4.664.90
52-Week Range
$4.507.13
Bid/Ask
$4.25 / $4.94
Market Cap
$63.35 Mil
Volume/Avg
917 / 7,662

Key Statistics

Price/Earnings (Normalized)
Price/Sales
1.32
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield
0.95%

Company Profile

Champions Oncology Inc is a USA based company which is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. They derive revenue primarily from research services.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Value
Total Number of Employees
306

Comparables

Valuation

Metric
CSBR
ADPT
ANAB
Price/Earnings (Normalized)
Price/Book Value
2.2521.13
Price/Sales
1.323.4942.87
Price/Cash Flow
Price/Earnings
CSBR
ADPT
ANAB

Financial Strength

Metric
CSBR
ADPT
ANAB
Quick Ratio
0.564.2311.20
Current Ratio
0.634.5111.53
Interest Coverage
−16.48−8.08
Quick Ratio
CSBR
ADPT
ANAB

Profitability

Metric
CSBR
ADPT
ANAB
Return on Assets (Normalized)
−19.70%−17.89%−25.16%
Return on Equity (Normalized)
−1,072.78%−36.02%−101.95%
Return on Invested Capital (Normalized)
−66.88%−28.77%−87.63%
Return on Assets
CSBR
ADPT
ANAB
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Novo Nordisk A/S ADR
NVO
VqskfybbWkfy$599.4 Bil
Vertex Pharmaceuticals Inc
VRTX
KwkrrgsXdfggf$126.5 Bil
Regeneron Pharmaceuticals Inc
REGN
ZnpvtbyrNbcrpkg$116.3 Bil
Moderna Inc
MRNA
ZdqznfzhvBnk$46.5 Bil
Alnylam Pharmaceuticals Inc
ALNY
MfzvzxzjpSzbjmq$29.6 Bil
argenx SE ADR
ARGX
XtjdymdZyvzd$28.0 Bil
BioNTech SE ADR
BNTX
CxsgxrlqWlmg$20.6 Bil
Biomarin Pharmaceutical Inc
BMRN
XlqryqfmNflgdhq$16.0 Bil
United Therapeutics Corp
UTHR
RrzgmgdWmk$14.9 Bil
Incyte Corp
INCY
LwlryjcThlfyx$13.0 Bil

Sponsor Center